Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles (EVs) Modulate Monocytes to Become CLL-Supportive Cells
International Journal of Molecular Sciences · 21.05.2026 · 27 (10) · 4638
DOI: 10.3390/ijms27104638 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.05.2026. Verfasst von Shaked Noah und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva 4941492, Israel. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Monocytes, Extracellular Vesicles. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In light of our previous publication, we hypothesized that chronic lymphocytic leukemia (CLL) cells also recruit monocytes to acquire survival advantage. To test this, we treated Buffy coat-driven monocytes with exosomes isolated from the peripheral blood of 45 treatment-naïve patients. The CLL-derived exosomes turned monocytes into IL-6-producing cells as an increase of 13-fold in the IL-6 levels was obtained in the growth medium of the exposed monocytes. Subsequently, we filtered out the monocytes and added CLL cells to this IL-6 enriched medium. As a result, the oncogene STAT3 became phosphorylated, and thus may have provided the cells with a survival advantage. A total of 67 phosphoproteins were upregulated in response to CLL-derived exosomal exposure in the recipient monocytes, with TFIIF being among the top scored proteins in this analysis. Transfection of monocytes with a TFIIF-containing vector increased the levels of IL-6 about 14-fold in the culture medium. Importantly, the CLL-derived exosomes induced the transformation of a portion of the recipient monocytes (45% compared to 30% of the unexposed cells) to become nurse-like fibrocyte cells. Taken together, CLL cells communicate with monocytes through the exosomes that they release. Once they are taken up by monocytes, they turn them into IL-6-producing cells, which provide a survival advantage to the neoplastic cells, creating a vicious circle that promotes disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva 4941492, Israel.
- Institute of Hematology, Davidoff Cancer Center, Petah Tikva 4941492, Israel.
- The Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Ramat-Aviv, Tel Aviv 6139001, Israel.
ORCID-Profile: Aladin Samara, Orit Uziel
Zitieren
APA
Noah, S., Be'ery, E., Sarsor, Z., Samara, A., Raanani, P., & Uziel, O. (2026). Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles (EVs) Modulate Monocytes to Become CLL-Supportive Cells. International Journal of Molecular Sciences, 27(10), 4638. https://doi.org/10.3390/ijms27104638
Vancouver
Noah S, Be'ery E, Sarsor Z, Samara A, Raanani P, Uziel O. Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles (EVs) Modulate Monocytes to Become CLL-Supportive Cells. International Journal of Molecular Sciences. 2026;27(10):4638. doi:10.3390/ijms27104638
BibTeX
@article{Noah2026,
author = {Noah, Shaked and Be'ery, Einat and Sarsor, Zinab and Samara, Aladin and Raanani, Pia and Uziel, Orit},
title = {Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles (EVs) Modulate Monocytes to Become CLL-Supportive Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4638},
doi = {10.3390/ijms27104638}
}
EUVIMED